Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
8.00
+0.47 (6.24%)
At close: Dec 5, 2025, 4:00 PM EST
8.07
+0.07 (0.88%)
After-hours: Dec 5, 2025, 6:59 PM EST
Cross Country Healthcare Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Cross Country Healthcare stock have an average target of 17.56, with a low estimate of 16.5 and a high estimate of 18.61. The average target predicts an increase of 119.50% from the current stock price of 8.00.
Analyst Consensus: Hold
* Price targets were last updated on Jun 17, 2025.
Analyst Ratings
The average analyst rating for Cross Country Healthcare stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +132.63% | Jun 17, 2025 |
| UBS | UBS | Hold Maintains $19 → $17 | Hold | Maintains | $19 → $17 | +106.25% | May 13, 2025 |
| Barrington Research | Barrington Research | Hold Maintains $19 | Hold | Maintains | $19 | +132.63% | Mar 14, 2025 |
| UBS | UBS | Hold Maintains $14 → $19 | Hold | Maintains | $14 → $19 | +132.63% | Mar 6, 2025 |
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 6, 2025 |
Financial Forecast
Revenue This Year
1.10B
from 1.34B
Decreased by -18.45%
Revenue Next Year
1.03B
from 1.10B
Decreased by -6.11%
EPS This Year
0.11
from -0.44
EPS Next Year
0.13
from 0.11
Increased by 21.43%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.1B | 1.1B | |
| Avg | 1.1B | 1.0B | |
| Low | 1.0B | 968.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -15.4% | 1.3% | |
| Avg | -18.5% | -6.1% | |
| Low | -22.3% | -11.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.13 | 0.18 | |
| Avg | 0.11 | 0.13 | |
| Low | 0.08 | 0.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 66.7% | |
| Avg | - | 21.4% | |
| Low | - | -45.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.